Literature DB >> 26034373

Differential diagnosis of pancreatic cancer by single-shot echo-planar imaging diffusion-weighted imaging.

Ben-Zu Hong1, Xin-Feng Li1, Jian-Qing Lin1.   

Abstract

AIM: To investigate the diagnostic ability of single-shot echo-planar imaging (EPI) diffusion-weighted imaging (DWI) to differentiate between malignant and benign pancreatic lesions.
METHODS: A computerized search was performed on PubMed, MEDLINE and EMBASE up to August 2014. Nine studies (10 sets of data) with a total of 304 malignant pancreatic lesions and 188 benign pancreatic lesions were included. The characteristics of each study included the study name, year of publication, magnetic resonance modalities used, patient population, strength of field, pulse time, repetition time, echo time (TE), maximum b factor, mean age, mean body weight, fat suppression, number of benign and malignant lesions, and true positive, true negative, false positive and false negative results. All analyses were performed using Meta-DiSc and Stata 11.0.
RESULTS: The pooled sensitivity and specificity of single-shot EPI DWI were 0.83 (95%CI: 0.79-0.87) and 0.77 (95%CI: 0.70-0.83), respectively. The positive likelihood ratio and negative likelihood ratio were 5.09 (95%CI: 2.19-11.84) and 0.23 (95%CI: 0.15-0.36), respectively. The P value for the χ(2) heterogeneity for all pooled estimates was < 0.05. From the fitted summary receiver operating characteristic curve, the area under the curve and Q* index were 0.89 and 0.82, respectively. Publication bias was not present (t = 0.58, P = 0.58). Meta-regression analysis indicated that fat suppression, mean age, TE, and maximum b factor were not sources of heterogeneity (all P > 0.05).
CONCLUSION: Single-shot EPI DWI is useful to differentiate between malignant and benign pancreatic lesions. Lesion size ≥ 2 cm is the limit for the diagnosis of early lesions.

Entities:  

Keywords:  Differential diagnosis; Diffusion-weighted imaging; Meta-analysis; Pancreatic cancer; Single-shot echo-planar imaging

Mesh:

Year:  2015        PMID: 26034373      PMCID: PMC4445115          DOI: 10.3748/wjg.v21.i20.6374

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings.

Authors:  Ali Muhi; Tomoaki Ichikawa; Utaroh Motosugi; Hironobu Sou; Katsuhiro Sano; Tatsuaki Tsukamoto; Zareen Fatima; Tsutomu Araki
Journal:  J Magn Reson Imaging       Date:  2011-11-08       Impact factor: 4.813

2.  Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade.

Authors:  Yi Wang; Zongming E Chen; Paul Nikolaidis; Robert J McCarthy; Laura Merrick; Laura A Sternick; Jeanne M Horowitz; Vahid Yaghmai; Frank H Miller
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

3.  Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI.

Authors:  Terumi Kamisawa; Kensuke Takuma; Hajime Anjiki; Naoto Egawa; Tastuo Hata; Masanao Kurata; Goro Honda; Kouji Tsuruta; Mizuka Suzuki; Noriko Kamata; Tsuneo Sasaki
Journal:  Am J Gastroenterol       Date:  2010-03-09       Impact factor: 10.864

4.  Value of diffusion-weighted magnetic resonance images for discrimination of focal benign and malignant hepatic lesions: a meta-analysis.

Authors:  Dong Xia; Jiyong Jing; Haiping Shen; Jianjun Wu
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

5.  Diffusion-weighted imaging in characterization of cystic pancreatic lesions.

Authors:  K Sandrasegaran; F M Akisik; A A Patel; M Rydberg; H M Cramer; N P Agaram; C M Schmidt
Journal:  Clin Radiol       Date:  2011-05-20       Impact factor: 2.350

6.  Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy.

Authors:  T Niwa; M Ueno; S Ohkawa; T Yoshida; T Doiuchi; K Ito; T Inoue
Journal:  Br J Radiol       Date:  2009-01       Impact factor: 3.039

7.  Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0T.

Authors:  Xiu-Zhong Yao; Hong Yun; Meng-Su Zeng; He Wang; Fei Sun; Sheng-Xiang Rao; Yuan Ji
Journal:  Magn Reson Imaging       Date:  2012-11-29       Impact factor: 2.546

8.  [Diffusion-weighted MR imaging; the significance of ADC and perfusion values in the differential diagnosis of pancreatic adenocarcinoma and mass forming pancreatitis].

Authors:  Tamás Puskás; Imre Henits
Journal:  Orv Hetil       Date:  2012-07-29       Impact factor: 0.540

9.  Diffusion-weighted magnetic resonance imaging of pancreas tumours.

Authors:  Nikolaos Kartalis; Terri L Lindholm; Peter Aspelin; Johan Permert; Nils Albiin
Journal:  Eur Radiol       Date:  2009-03-24       Impact factor: 5.315

10.  Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions.

Authors:  Xin Chen; Wen-ling Li; Yi-li Zhang; Qian Wu; You-min Guo; Zhi-lan Bai
Journal:  BMC Cancer       Date:  2010-12-29       Impact factor: 4.430

View more
  2 in total

1.  Scan time reduction in diffusion-weighted imaging of the pancreas using a simultaneous multislice technique with different acceleration factors: How fast can we go?

Authors:  Jana Taron; Petros Martirosian; Thomas Kuestner; Nina F Schwenzer; Ahmed Othman; Jakob Weiß; Mike Notohamiprodjo; Konstantin Nikolaou; Christina Schraml
Journal:  Eur Radiol       Date:  2017-11-13       Impact factor: 5.315

Review 2.  Diffusion weighted imaging: Technique and applications.

Authors:  Vinit Baliyan; Chandan J Das; Raju Sharma; Arun Kumar Gupta
Journal:  World J Radiol       Date:  2016-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.